SANTA BARBARA, Calif.--(BUSINESS WIRE)--Strategic Healthcare Programs, LLC (SHP), a healthcare data analytics and benchmarking company, announced the addition of Integrated Alerting to the existing ...

SEATTLE, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced that the Company presented new preclinical data highlighting the therapeutic ...

Strategic Healthcare Programs, LLC (), the leading healthcare performance improvement and benchmarking company for the post-acute market, announces the release of the tenth automated data interface ...

Despite GTPase KRAS being the most common mutated oncogene in human cancers, there is still an unmet medical need for treating KRAS G12C-mutated cancers.